In conclusion, our study reveals that circKEAP1 competitively binds miR-141-3p to abolish the suppressive effect of miR-141-3p on KEAP1, which results to suppress the NRF2/HDAC4 signal pathway and inhibit tumor progress. Here, HDAC4 is linked to neoplasm.